{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T05:16:21Z","timestamp":1790745381133,"version":"4.1.0"},"reference-count":38,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100002701","name":"Ministry of Education","doi-asserted-by":"publisher","award":["NRF-2015R1D1A3A01019018)"],"award-info":[{"award-number":["NRF-2015R1D1A3A01019018)"]}],"id":[{"id":"10.13039\/501100002701","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Korea government","award":["2017R1A3B1023418"],"award-info":[{"award-number":["2017R1A3B1023418"]}]},{"name":"Korea government","award":["2014R1A5A2009242"],"award-info":[{"award-number":["2014R1A5A2009242"]}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Nanomedicine: Nanotechnology, Biology and Medicine"],"published-print":{"date-parts":[[2018,4]]},"DOI":"10.1016\/j.nano.2017.12.022","type":"journal-article","created":{"date-parts":[[2018,1,6]],"date-time":"2018-01-06T04:38:23Z","timestamp":1515213503000},"page":"633-642","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"title":["A targeted ferritin-microplasmin based thrombolytic nanocage selectively dissolves blood clots"],"prefix":"10.1016","volume":"14","author":[{"given":"Junyoung","family":"Seo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taslim A.","family":"Al-Hilal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun-Goo","family":"Jee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong-Lim","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ha-Jeong","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Byung-Heon","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soyoun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"In-San","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nano.2017.12.022_bb0005","first-page":"e29","article-title":"Heart disease and stroke statistics--2015 update: a report from the American Heart Association","volume":"131","author":"Mozaffarian","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.nano.2017.12.022_bb0010","doi-asserted-by":"crossref","first-page":"2331","DOI":"10.1172\/JCI60229","article-title":"New insights into the mechanisms of venous thrombosis","volume":"122","author":"Mackman","year":"2012","journal-title":"J Clin Invest"},{"key":"10.1016\/j.nano.2017.12.022_bb0015","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1001\/jama.2015.3058","article-title":"Acute stroke intervention: a systematic review","volume":"313","author":"Prabhakaran","year":"2015","journal-title":"JAMA"},{"issue":"7","key":"10.1016\/j.nano.2017.12.022_bb0020","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/j.jcin.2015.12.268","article-title":"Inferior vena cava thrombosis","volume":"9","author":"Alkhouli","year":"2016","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.nano.2017.12.022_bb0025","doi-asserted-by":"crossref","first-page":"2341","DOI":"10.1161\/STROKEAHA.114.007564","article-title":"Twenty-Year history of the evolution of stroke thrombolysis with intravenous alteplase to reduce long-term disability","volume":"46","author":"Campbell","year":"2015","journal-title":"Stroke"},{"key":"10.1016\/j.nano.2017.12.022_bb0030","doi-asserted-by":"crossref","first-page":"145","DOI":"10.2174\/18715273113129990057","article-title":"Thrombolytic agents for acute ischaemic stroke treatment: the past, present and future","volume":"12","author":"Balami","year":"2013","journal-title":"CNS Neurol Disord Drug Targets"},{"key":"10.1016\/j.nano.2017.12.022_bb0035","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1016\/S0140-6736(14)60584-5","article-title":"Effect of treatment delay, age, and stroke severity on the effects of intravenous thrombolysis with alteplase for acute ischaemic stroke: a meta-analysis of individual patient data from randomised trials","volume":"384","author":"Emberson","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.nano.2017.12.022_bb0040","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1056\/NEJM199512143332401","article-title":"Tissue plasminogen activator for acute ischemic stroke","volume":"333","author":"The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1016\/j.nano.2017.12.022_bb0045","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/j.avsg.2009.12.011","article-title":"The association of periprocedural hypertension and adverse outcomes in patients undergoing catheter-directed thrombolysis","volume":"24","author":"Agle","year":"2010","journal-title":"Ann Vasc Surg"},{"issue":"Suppl 1","key":"10.1016\/j.nano.2017.12.022_bb0050","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1111\/j.1538-7836.2011.04370.x","article-title":"Historical perspective and future direction of thrombolysis research: the re-discovery of plasmin","volume":"9","author":"Marder","year":"2011","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.nano.2017.12.022_bb0055","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1046\/j.1538-7836.2003.00078.x","article-title":"Recombinant human microplasmin: production and potential therapeutic properties","volume":"1","author":"Nagai","year":"2003","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.nano.2017.12.022_bb0060","doi-asserted-by":"crossref","first-page":"2311","DOI":"10.1161\/01.STR.0000182100.65262.46","article-title":"Extending reperfusion therapy for acute ischemic stroke: emerging pharmacological, mechanical, and imaging strategies","volume":"36","author":"Molina","year":"2005","journal-title":"Stroke"},{"key":"10.1016\/j.nano.2017.12.022_bb0065","doi-asserted-by":"crossref","first-page":"2279","DOI":"10.1161\/01.STR.0000028267.09604.7B","article-title":"Microplasmin: a novel thrombolytic that improves behavioral outcome after embolic strokes in rabbits","volume":"33","author":"Lapchak","year":"2002","journal-title":"Stroke"},{"key":"10.1016\/j.nano.2017.12.022_bb0070","doi-asserted-by":"crossref","first-page":"3789","DOI":"10.1161\/STROKEAHA.109.560201","article-title":"Randomized, placebo-controlled, dose-ranging clinical trial of intravenous microplasmin in patients with acute ischemic stroke","volume":"40","author":"Thijs","year":"2009","journal-title":"Stroke"},{"key":"10.1016\/j.nano.2017.12.022_bb0075","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1007\/s40265-013-0124-1","article-title":"Ocriplasmin: a review of its use in patients with symptomatic vitreomacular adhesion","volume":"73","author":"Syed","year":"2013","journal-title":"Drugs"},{"key":"10.1016\/j.nano.2017.12.022_bb0080","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.2217\/nnm.11.179","article-title":"Multifunctional nanoagent for thrombus-targeted fibrinolytic therapy","volume":"7","author":"McCarthy","year":"2012","journal-title":"Nanomedicine (Lond)"},{"key":"10.1016\/j.nano.2017.12.022_bb0085","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.biomaterials.2015.12.009","article-title":"Tissue plasminogen activator followed by antioxidant-loaded nanoparticle delivery promotes activation\/mobilization of progenitor cells in infarcted rat brain","volume":"81","author":"Petro","year":"2016","journal-title":"Biomaterials"},{"key":"10.1016\/j.nano.2017.12.022_bb0090","doi-asserted-by":"crossref","first-page":"7462","DOI":"10.1021\/nn403184u","article-title":"Designed nanocage displaying ligand-specific Peptide bunches for high affinity and biological activity","volume":"7","author":"Jeon","year":"2013","journal-title":"ACS Nano"},{"key":"10.1016\/j.nano.2017.12.022_bb0095","doi-asserted-by":"crossref","first-page":"4705","DOI":"10.1021\/nn500454n","article-title":"A smart platform for hyperthermia application in cancer treatment: cobalt-doped ferrite nanoparticles mineralized in human ferritin cages","volume":"8","author":"Fantechi","year":"2014","journal-title":"ACS Nano"},{"key":"10.1016\/j.nano.2017.12.022_bb0100","doi-asserted-by":"crossref","first-page":"8167","DOI":"10.1021\/nn403465a","article-title":"Think modular: a simple apoferritin-based platform for the multifaceted detection of pancreatic cancer","volume":"7","author":"Hwang","year":"2013","journal-title":"ACS Nano"},{"key":"10.1016\/j.nano.2017.12.022_bb0105","doi-asserted-by":"crossref","first-page":"10879","DOI":"10.1021\/nn404325t","article-title":"Proteinticle engineering for accurate 3D diagnosis","volume":"7","author":"Lee","year":"2013","journal-title":"ACS Nano"},{"key":"10.1016\/j.nano.2017.12.022_bb0110","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1021\/acs.biomac.5b01134","article-title":"Double-chambered ferritin platform: dual-function payloads of cytotoxic peptides and fluorescent protein","volume":"17","author":"Kim","year":"2016","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.nano.2017.12.022_bb0115","doi-asserted-by":"crossref","first-page":"6637","DOI":"10.1002\/adma.201503093","article-title":"A double-chambered protein nanocage loaded with thrombin receptor agonist peptide (TRAP) and gamma-carboxyglutamic acid of protein C (PC-Gla) for sepsis treatment","volume":"27","author":"Lee","year":"2015","journal-title":"Adv Mater"},{"key":"10.1016\/j.nano.2017.12.022_bb0120","doi-asserted-by":"crossref","first-page":"2800","DOI":"10.1073\/pnas.0511219103","article-title":"Peptides selected for binding to clotted plasma accumulate in tumor stroma and wounds","volume":"103","author":"Pilch","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.nano.2017.12.022_bb0125","doi-asserted-by":"crossref","first-page":"5834","DOI":"10.1021\/ac200657s","article-title":"Fluorescent ferritin nanoparticles and application to the aptamer sensor","volume":"83","author":"Kim","year":"2011","journal-title":"Anal Chem"},{"key":"10.1016\/j.nano.2017.12.022_bb0130","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1146\/annurev.biophys.29.1.291","article-title":"Comparative protein structure modeling of genes and genomes","volume":"29","author":"Marti-Renom","year":"2000","journal-title":"Annu Rev Biophys Biomol Struct"},{"key":"10.1016\/j.nano.2017.12.022_bb0135","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1093\/bioinformatics\/btt055","article-title":"a high-throughput and highly parallel open source molecular simulation toolkit","volume":"29","author":"Pronk","year":"2013","journal-title":"Bioinformatics"},{"key":"10.1016\/j.nano.2017.12.022_bb0140","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1021\/bc9001163","article-title":"A. Multimodal nanoagents for the detection of intravascular thrombi","volume":"20","author":"McCarthy","year":"2009","journal-title":"Bioconjug Chem"},{"key":"10.1016\/j.nano.2017.12.022_bb0145","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1182\/blood.V95.3.943.003k34_943_951","article-title":"Proteolytic processing of human coagulation factor IX by plasmin","volume":"95","author":"Samis","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.nano.2017.12.022_bb0150","doi-asserted-by":"crossref","first-page":"3086","DOI":"10.1182\/blood.V97.10.3086","article-title":"Depletion of circulating alpha(2)-antiplasmin by intravenous plasmin or immunoneutralization reduces focal cerebral ischemic injury in the absence of arterial recanalization","volume":"97","author":"Nagai","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.nano.2017.12.022_bb0155","doi-asserted-by":"crossref","first-page":"2756","DOI":"10.1172\/JCI116893","article-title":"Plasminogen activator inhibitor-1 gene-deficient mice. II. Effects on hemostasis, thrombosis, and thrombolysis","volume":"92","author":"Carmeliet","year":"1993","journal-title":"J Clin Invest"},{"key":"10.1016\/j.nano.2017.12.022_bb0160","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1097\/MBC.0b013e3283518815","article-title":"Algal fucoidan, unlike heparin, has thrombolytic activity in a murine arterial thrombosis model","volume":"23","author":"Min","year":"2012","journal-title":"Blood Coagul Fibrinolysis"},{"key":"10.1016\/j.nano.2017.12.022_bb0165","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1160\/TH10-07-0484","article-title":"Pharmacokinetic evaluation of an oral tablet form of low-molecular-weight heparin and deoxycholic acid conjugate as a novel oral anticoagulant","volume":"105","author":"Park","year":"2011","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.nano.2017.12.022_bb0170","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0968-0004(99)01521-2","article-title":"Molecular mechanisms of plasminogen activation: bacterial cofactors provide clues","volume":"25","author":"Parry","year":"2000","journal-title":"Trends Biochem Sci"},{"key":"10.1016\/j.nano.2017.12.022_bb0175","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1111\/j.1538-7836.2004.00889.x","article-title":"Comparative effects of microplasmin and tissue-type plasminogen activator (tPA) on cerebral hemorrhage in a middle cerebral artery occlusion model in mice","volume":"2","author":"Suzuki","year":"2004","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.nano.2017.12.022_bb0180","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/j.jvs.2010.09.017","article-title":"Antithrombotic effect of grape seed proanthocyanidins extract in a rat model of deep vein thrombosis","volume":"53","author":"Zhang","year":"2011","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.nano.2017.12.022_bb0185","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1001\/jamaneurol.2014.2886","article-title":"Targeted drug delivery to flow-obstructed blood vessels using mechanically activated nanotherapeutics","volume":"72","author":"Korin","year":"2015","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.nano.2017.12.022_bb0190","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.jconrel.2013.12.017","article-title":"Complex adaptive therapeutic strategy (CATS) for cancer","volume":"175","author":"Cho","year":"2014","journal-title":"J Control Release"}],"container-title":["Nanomedicine: Nanotechnology, Biology and Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1549963418300078?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1549963418300078?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,10,25]],"date-time":"2020-10-25T08:25:28Z","timestamp":1603614328000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1549963418300078"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4]]},"references-count":38,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018,4]]}},"alternative-id":["S1549963418300078"],"URL":"https:\/\/doi.org\/10.1016\/j.nano.2017.12.022","relation":{},"ISSN":["1549-9634"],"issn-type":[{"value":"1549-9634","type":"print"}],"subject":[],"published":{"date-parts":[[2018,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A targeted ferritin-microplasmin based thrombolytic nanocage selectively dissolves blood clots","name":"articletitle","label":"Article Title"},{"value":"Nanomedicine: Nanotechnology, Biology and Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nano.2017.12.022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}